HealthStream, Inc. (NASDAQ:HSTM) Expected to Post Quarterly Sales of $62.20 Million

Equities analysts expect HealthStream, Inc. (NASDAQ:HSTM) to report sales of $62.20 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for HealthStream’s earnings. The highest sales estimate is $62.69 million and the lowest is $61.70 million. HealthStream posted sales of $59.93 million in the same quarter last year, which indicates a positive year over year growth rate of 3.8%. The business is scheduled to announce its next quarterly earnings report after the market closes on Monday, October 21st.

On average, analysts expect that HealthStream will report full-year sales of $253.89 million for the current year, with estimates ranging from $253.20 million to $254.57 million. For the next fiscal year, analysts forecast that the firm will post sales of $253.69 million, with estimates ranging from $253.37 million to $254.00 million. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for HealthStream.

HealthStream (NASDAQ:HSTM) last issued its earnings results on Monday, July 22nd. The technology company reported $0.07 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.07. HealthStream had a return on equity of 4.22% and a net margin of 5.71%. The company had revenue of $63.78 million during the quarter, compared to the consensus estimate of $63.12 million. During the same period in the previous year, the company posted $0.11 EPS. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year.

HSTM has been the topic of a number of recent research reports. ValuEngine raised shares of HealthStream from a “hold” rating to a “buy” rating in a research report on Tuesday, July 9th. BidaskClub downgraded shares of HealthStream from a “buy” rating to a “hold” rating in a report on Wednesday, August 28th. Zacks Investment Research lowered shares of HealthStream from a “buy” rating to a “hold” rating in a research report on Tuesday, October 1st. Finally, Barrington Research reaffirmed a “market perform” rating on shares of HealthStream in a report on Thursday, July 25th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $28.00.

In other news, Director Jeffrey L. Mclaren sold 5,000 shares of the company’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $28.58, for a total transaction of $142,900.00. Following the completion of the sale, the director now directly owns 14,193 shares in the company, valued at approximately $405,635.94. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 20.40% of the stock is owned by insiders.

Several large investors have recently modified their holdings of the company. Jacobs Levy Equity Management Inc. raised its holdings in shares of HealthStream by 3.2% during the 2nd quarter. Jacobs Levy Equity Management Inc. now owns 172,700 shares of the technology company’s stock worth $4,466,000 after buying an additional 5,320 shares in the last quarter. Panagora Asset Management Inc. raised its stake in HealthStream by 0.6% during the second quarter. Panagora Asset Management Inc. now owns 391,521 shares of the technology company’s stock worth $10,125,000 after acquiring an additional 2,426 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of HealthStream by 1.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 150,039 shares of the technology company’s stock worth $3,881,000 after acquiring an additional 2,522 shares during the last quarter. Resources Investment Advisors LLC. lifted its holdings in shares of HealthStream by 13.0% in the second quarter. Resources Investment Advisors LLC. now owns 3,900 shares of the technology company’s stock worth $101,000 after acquiring an additional 450 shares during the last quarter. Finally, Invesco Ltd. lifted its holdings in shares of HealthStream by 16.4% in the second quarter. Invesco Ltd. now owns 695,095 shares of the technology company’s stock worth $17,975,000 after acquiring an additional 97,729 shares during the last quarter. Institutional investors own 72.72% of the company’s stock.

Shares of HealthStream stock traded up $0.17 during trading on Wednesday, reaching $26.33. The company’s stock had a trading volume of 71,832 shares, compared to its average volume of 125,227. The company has a quick ratio of 2.18, a current ratio of 2.18 and a debt-to-equity ratio of 0.10. The business’s 50-day moving average price is $26.06 and its 200-day moving average price is $26.46. HealthStream has a 52 week low of $23.06 and a 52 week high of $30.00. The firm has a market cap of $854.89 million, a PE ratio of 61.23, a P/E/G ratio of 5.77 and a beta of 0.69.

HealthStream Company Profile

HealthStream, Inc provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the training, certification, assessment, development, clinical development, talent management, performance appraisal, and other needs, as well as training, implementation, and account management services for the healthcare community.

Featured Story: What is the Gross Domestic Product (GDP)?

Get a free copy of the Zacks research report on HealthStream (HSTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.